|
PTBP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.237800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.915800E-01 |
| Normal-vs-Stage2 |
4.173600E-01 |
| Normal-vs-Stage3 |
7.575900E-02 |
| Normal-vs-Stage4 |
6.449600E-01 |
| Stage1-vs-Stage2 |
6.468600E-01 |
| Stage1-vs-Stage3 |
1.576140E-02 |
| Stage1-vs-Stage4 |
4.101600E-01 |
| Stage2-vs-Stage3 |
8.713600E-02 |
| Stage2-vs-Stage4 |
3.728000E-01 |
| Stage3-vs-Stage4 |
6.836800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.448000E-01 |
| Normal-vs-AfricanAmerican |
8.014000E-01 |
| Normal-vs-Asian |
4.663800E-02 |
| Caucasian-vs-AfricanAmerican |
7.287600E-01 |
| Caucasian-vs-Asian |
5.826700E-04 |
| AfricanAmerican-vs-Asian |
3.443800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.192000E-01 |
| Normal-vs-Female |
7.015800E-01 |
| Male-vs-Female |
9.735200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.615200E-01 |
| Normal-vs-Extreme_Weight |
4.514400E-01 |
| Normal-vs-Obese |
9.225600E-01 |
| Normal-vs-Extreme_Obese |
5.148800E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.549800E-01 |
| Normal_Weight-vs-Obese |
7.079800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.171400E-01 |
| Extreme_Weight-vs-Obese |
4.281600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.775000E-01 |
| Obese-vs-Extreme_Obese |
5.016400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.556400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.778000E-02 |
| Normal-vs-Age(61-80Yrs) |
7.409800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.685800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.880200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.219000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.667590E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.580100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.944100E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.964580E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.288300E-02 |
| Normal-VS-Type2 PRCC |
2.981700E-03 |
| Normal-VS-KIRP CIMP |
3.29499999951466E-07 |
| Normal-VS-Unclassified PRCC |
2.226200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.75139999672547E-08 |
| Type1 PRCC-VS-KIRP CIMP |
1.02280406366617E-11 |
| Type1 PRCC-VS-Unclassified PRCC |
8.445200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.587960E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.157100E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
3.0675000000091E-06 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.276800E-01 |
| Normal-vs-N1 |
3.122200E-01 |
| Normal-vs-N2 |
9.315400E-01 |
| N0-vs-N1 |
7.637200E-01 |
| N0-vs-N2 |
7.972000E-01 |
| N1-vs-N2 |
5.979200E-01 |
|
|
